HomeAI · summaries
Storia in 8 fonti
Post-Hoc Live: Marty Makary's FDA downfall and legacy
Endpoints News and Financial Times journalists discuss the downfall of FDA Commissioner Marty Makary, live in New York at the FT's biotech and pharma summit.
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
statnews.com
Makary departs FDA amid turmoil as Diamantas, agency's top food official, steps in
Food and Drug Administration Commissioner Marty Makary is resigning from his role after a tumultuous tenure.
- ·
axios.com
Marty Makary out as FDA chief
His tenure was marked by organizational upheaval, controversies over drug approvals and tensions with the White House.
- ·
politico.com
Makary’s time atop FDA over, Diamantas named acting commissioner
The gastrointestinal surgeon’s tenure was marked by mass layoffs, persistent churn among senior leaders and policy fights.
- ·
Why Marty Makary was the worst FDA commissioner in 25 years
Marty Makary, who resigned under pressure from the FDA, brought to the job a fundamental lack of understanding of the nature of the role, STAT's Matthew Herper writes.
- ·
endpoints.news
Post-Hoc: What brought down the FDA commissioner
Marty Makary resigned as FDA commissioner Tuesday. The next commissioner will inherit the same punishing contradictions, and a weaker, politicized agency.
- ·
washingtonpost.com
Opinion | A desperately needed reset at the FDA
What Marty Makary's successor can learn from his mistakes.
- ·
thedispatch.com
Marty Makary’s Turbulent Tenure at FDA Comes to an End
Brought in as an agency critic, the commissioner drew fire from drug developers and abortion foes.
- ·
medpagetoday.com
Opinion | Here's How FDA Employees Learned Their Boss Was Really Gone
The removal of Marty Makary's portrait was the first real indication from the inside
- ·
Post-Hoc Live: Marty Makary's FDA downfall and legacy
Endpoints News and Financial Times journalists discuss the downfall of FDA Commissioner Marty Makary, live in New York at the FT's biotech and pharma summit.
- ·
fiercepharma.com
After Makary departure, CDER chief Tracy Beth Høeg likely headed out at FDA: report
With the ink barely dry on outgoing commissioner Marty Makary’s resignation, another top regulator may be heading for the exit at the FDA. | With the ink barely dry on outgoing…
- ·
Makary resigns; Biogen reports Alzheimer’s data; and more
Welcome back to Endpoints Weekly. The biggest news this week was Marty Makary’s resignation from his role as FDA Commissioner. The announcement came days after reports emerged…